GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
JRARX
Price
$70.36
Change
-$4.19 (-5.62%)
Updated
Apr 3 closing price
Net Assets
24.27B
Ad is loading...

GFACX vs JRARX

Header iconGFACX vs JRARX Comparison
Open Charts GFACX vs JRARXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
Janus Henderson Research R
Price$70.36
Change-$4.19 (-5.62%)
VolumeN/A
Net Assets24.27B
GFACX vs JRARX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. JRARX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and JRARX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. JRARX (24.3B). GFACX (0.00) and JRARX (0.00) have matching dividends . GFACX was incepted earlier than JRARX: GFACX (24 years) vs JRARX (8 years). JRARX (1.38) and GFACX (1.36) have similar cost to investors . JRARX is a more actively managed with annual turnover of: 27.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than JRARX: GFACX (250) vs JRARX (2500). JRARX annual gain was more profitable for investors over the last year : 2.00 vs. GFACX (-1.75). JRARX return over 5 years is better than : 86.70 vs. GFACX (59.73).
GFACXJRARXGFACX / JRARX
Total Expense Ratio1.361.32103%
Annual Report Gross Expense Ratio1.361.3899%
Fund Existence24 years8 years-
Gain YTD-5.003-8.19061%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets280B24.3B1,152%
Annual Yield % from dividends0.000.00-
Returns for 1 year-1.752.00-88%
Returns for 3 years0.6323.163%
Returns for 5 years59.7386.7069%
Returns for 10 years44.46N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences